Main components of Bipolar Disorder
Abstract
Mental disorders such as Bipolar Disorder (TB) have increased their incidence in the last decade worldwide, so currently in Mexico; they represent a great challenge in the area of Psychiatry due to the high mortality rate due to suicides committed by the patients suffering from a Mental Disorder. This study is based on updated scientific review sources where it is intended to update and disclose the main genetic, chemical, and environmental risk factors that intervene etiologically in the production of mental instability that could subsequently trigger the presence of a Bipolar Disorder. , to publicize the clinical manifestations of this disease to provide an effective and timely diagnosis in patients, so that they return to their daily activities and not be disabling in their daily life.
Downloads
References
Agosti V, Stewart JW. Hypomania with and without Dysphoria: comparison of comorbidity and clinical characteristics of respondents from a national community sample. J Affect Disord. 2008;108(1–2):177–82.
Akiskal H, Benazzi F, Perugi G, Rihmer Z. Depresión “unipolar” agitada reconceptualizada como un estado mixto depresivo: implicaciones para la controversia antidepresivo-suicidio. J afectar el desorden. 2005; 85 (3): 245–58.
Akiskal H, Pinto O. The evolving bipolar spectrum. Psychiatr Clin North Am. 1999;22(3):517–34.
Baldessarini R, Tondo L, Vázquez GH. Tratamiento farmacológico del trastorno bipolar del adulto. Mol Psychiatry. 2019; 24 (2): 198–217.
Burkhardt E, Pfennig A, Leopold K. Constelaciones de riesgo clínico para el desarrollo de trastornos bipolares. Medicina (Kaunas). 2021; 57 (8): 792.
Cudney E, Frey BN, Streiner DL, Minuzzi L, Sassi RB. Biological rhythms are independently associated with quality of life in bipolar disorder. Int J Bipolar Disord [Internet]. 2016 Mar 16 [cited 2021 Sep 9]; 4:9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792817/
Cruz Ramírez KV, Benavides Solarte MF, Gómez Restrepo C. Elementos traza y trastorno afectivo bipolar. Univ Médica [Internet]. 2017;58(2). Available from: http://www.redalyc.org/articulo.oa?id=231053764006
D’Onofrio S, Mahaffey S, Garcia-Rill E. Role of calcium channels in bipolar disorder. Curr Psychopharmacol [Internet]. 2017 [cited 2021 Sep 9];6(2):122–35. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771645/
Esparza RP. Tratamiento farmacológico de la depresión: actualidades y futuras direcciones [Internet]. Medigraphic.com. [citado el 10 de septiembre de 2021]. Disponible en: https://www.medigraphic.com/pdfs/facmed/un-2017/un175b.pdf
Fabbri C. The role of genetics in bipolar disorder. En: Bipolar Disorder: From Neuroscience to Treatment. Cham: Springer International Publishing; 2020. p. 41–60. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181866/
García-Blanco AC, Sierra P, Livianos L. Nosología, epidemiología y etiopatogenia del trastorno bipolar: Últimas aproximaciones. Psiquiatr Biol. 2014;21(3):89–94.
Huber RS, Yurgelun-Todd DA. Neural mechanisms underlying suicide behavior in youth with bipolar disorder. Bipolar Disord [Internet]. 2020 Mar [cited 2021 Aug 19];22(2):193–4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216322/
Inteligencia Emocional en Pacientes con Trastorno Bipolar y Trastorno Límite de la Personalidad. UNIVERSIDAD DE MURCIA [Internet]. Digitum.um.es. [citado el 10 de septiembre de 2021]. Disponible en: https://digitum.um.es/digitum/bitstream/10201/53706/1/Jos%c3%a9%20Mar%c3%ada%20Salmer%c3%b3n%20Arias-Camis%c3%b3n%20Tesis%20Doctoral.pdf
Jiménez Arriero, M. A., Palomo ÁLvarez, T., & Rodríguez Jiménez, R. (s. f.). Fundamentos de Psiquiatría. Editorial Médica Panamericana.
Lorenzo-Luaces L, Amsterdam JD, Soeller I, DeRubeis RJ. Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk. Acta Psychiatr Scand. 2016;133(6):459–69.
Martínez Hernández O, Montalván Martínez O, Betancourt Izquierdo Y. Trastorno Bipolar. Consideraciones clínicas y epidemiológicas. Rev Méd Electrón [Internet]. 2019 Mar-Abr [citado: 02/07/21];41(2). Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/3157/42
McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, et al. Bipolar disorders. Lancet. 2020;396(10265):1841–56. https://pubmed.ncbi.nlm.nih.gov/33278937/
McCarty R, Josephs T, Kovtun O, Rosenthal SJ. Enlightened: addressing circadian and seasonal changes in photoperiod in animal models of bipolar disorder. Transl Psychiatry. 2021;11(1):373.
Mullan KA, Anderson A, Illing PT, Kwan P, Purcell AW, Mifsud NA. HLA-associated antiepileptic drug-induced cutaneous adverse reactions. HLA. 2019;93(6):417–35.
Ramírez Vargas, X., Arias Leal, M. L., & Madrigal Zamora, S. (2020). Actualización del trastorno afectivo bipolar. Revista Médica Sinergia, 5(9), e572.
Selle V, Schalkwijk S, Vázquez GH, Baldessarini RJ. Tratamientos para la depresión bipolar aguda: metanálisis de ensayos controlados con placebo en monoterapia de anticonvulsivos, litio y antipsicóticos. Farmacopsiquiatría. 2014; 47 (2): 43–52.
Suliman M, Schmidtke MW, Greenberg ML. El papel de la vía UPR en la fisiopatología y el tratamiento del trastorno bipolar. Neurosci de células frontales. 2021; 15: 735622.
Scaini G, Valvassori SS, Diaz AP, Lima CN, Benevenuto D, Fries GR, et al. Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings. Braz J Psychiatry [Internet]. 2020 Apr 3 [cited 2021 Aug 19];42(5):536–51. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524405/
Takaesu Y. Circadian rhythm in bipolar disorder: A review of the literature. Psychiatry Clin Neurosci. 2018 Sep;72(9):673–82.
Vázquez GH, Holtzman JN, Tondo L, Baldessarini RJ. Eficacia y tolerabilidad de los tratamientos para la depresión bipolar. J afectar el desorden. 2015; 183: 258–62.
Vázquez GH, Strejilevich S, García Bonetto G, Cetkovich-Bakmas M, Zaratiegui R, Lagomarsino A, et al. Argentine consensus on the treatment of bipolar disorders. Vertex. 2005;16 Suppl:3–24
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170.
